等待開盤 09-29 09:30:00 美东时间
+0.080
+2.04%
INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen
09-26 02:06
AltynGold Plc ( ($GB:ALTN) ) has shared an announcement. AltynGold Plc has appo...
09-25 14:28
Aclass actionlawsuit was filed againstAltimmune ($ALT) by Lev...
09-24 22:49
(来源:衡水日报) 转自:衡水日报 《Journal of Hepatology》本年度最新调查揭露,全世界非酒精性脂肪性肝病(NAFLD)中位数患病率已达 ...
09-23 10:36
Shares of companies focused on developing drugs for a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Thursday after Roche (OTCQX:RHHBY) (OTCQX:RHHBF) a...
09-18 22:41
U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points...
09-18 22:19
NEW BRITAIN, Conn., Sept. 18, 2025 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK) today announced that Bill Beck has been appointed President, Tools & Outdoor, effective October 1. Beck ...
09-18 21:32
(来源:衡水日报) 转自:衡水日报 深夜的加班灯、饭桌上的推杯换盏、父母日渐增多的药盒…… 生活里的细碎忙碌,总让我们轻易忽略发出的 “疲惫信号”。它沉默地承担...
09-17 14:39
Redwire Corporation (NYSE:RDW), a global leader in space and defense technology solutions, today announced that it has reached an agreement with Thales Alenia Space, a joint venture between Thales (67%) and Leonardo
09-16 19:35
Altimmune announced the appointment of Linda M. Richardson as Chief Commercial Officer. Richardson brings over 30 years of experience in sales, marketing, and business development across metabolic, hepatology, and cardiovascular therapeutic areas. Her expertise will support Altimmune's Phase 3 development of pemvidutide for MASH, AUD, ALD, and obesity. Richardson previously held leadership roles at Intercept Pharmaceuticals and Chimerix. Her addi...
09-15 11:30